Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV000012821 | SCV002023021 | pathogenic | Fanconi anemia complementation group D2 | 2019-06-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003522920 | SCV004286250 | pathogenic | Fanconi anemia | 2024-01-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln320*) in the FANCD2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCD2 are known to be pathogenic (PMID: 17436244). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Fanconi anemia (PMID: 11239453). ClinVar contains an entry for this variant (Variation ID: 12041). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000012821 | SCV000033061 | pathogenic | Fanconi anemia complementation group D2 | 2001-02-01 | no assertion criteria provided | literature only | |
Leiden Open Variation Database | RCV000012821 | SCV001364773 | pathogenic | Fanconi anemia complementation group D2 | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach. |